US factories lag in adopting AI. This drug manufacturer is an exception.
In a sterile Bristol Myers Squibb lab about an hour north of Boston, researchers in scrubs and hairnets transfer living cells into a 2,000-liter stainless steel bioreactor, growing them for weeks. The goal is to produce proteins that are genetically engineered to attack cells that cause disease. Small variations in heat, light or pH levels […]
US factories lag in adopting AI. This drug manufacturer is an exception. Read More »









